FDA approves new combination treatment for acute myeloid leukemiawmm2021-02-26T19:12:55-08:00April 28th, 2017|2017 Press Releases, Press Releases| Read more
Invivoscribe® Receives FDA Approval for the LeukoStrat® CDx FLT3 Mutation Assay Companion Diagnostic Test for the Selection of Patients for Rydapt® and is the First Companion Diagnostic for AMLwmm2021-02-26T19:13:02-08:00April 28th, 2017|2017 Press Releases, Press Releases| Read more
Molecular pathology diagnosis of diffuse large B cell lymphoma using BIOMED-2 clonal gene rearrangementsInvivoscribe Marketing2021-02-12T01:03:26-08:00April 27th, 2017|2017 Publications, Publications| Read more
A Small Case Series of Intravascular Large B-Cell Lymphoma with Unexpected Findings: Subset of Cases with Concomitant Extravascular Central Nervous System (CNS) Involvement Mimicking Primary CNS LymphomaInvivoscribe Marketing2021-02-12T01:10:12-08:00April 17th, 2017|2017 Publications, Publications| Read more